/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Chenglong Liu

Tongji University(CN)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

22

Papers

758

Citations

11

h-index

11

i10-index

Chenglong Liu is an academic researcher from Tongji University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Wnt/β-catenin signaling in development and cancer. The author has an h-index of 11, co-authored 19 publications.

ORCID: 0000-0002-1657-6683

Research Topics

Cancer Immunotherapy and Biomarkers Pancreatic and Hepatic Oncology Research Wnt/β-catenin signaling in development and cancer Cancer, Hypoxia, and Metabolism Peptidase Inhibition and Analysis

Papers by this author

works

Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19

2020 · Medicine in Drug Discovery · 83 citations

https://doi.org/10.1016/j.medidd.2020.100056

Chenglong Liu Albrecht von Brunn Di Zhu

Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer

2023 · Journal of Medicinal Chemistry · 12 citations

https://doi.org/10.1021/acs.jmedchem.2c01568

Hao Zhang Chenglong Liu Qiushi Chen Lian Shen

Research topics

topics

Cancer Immunotherapy and Biomarkers

Pancreatic and Hepatic Oncology Research

Wnt/β-catenin signaling in development and cancer

Cancer, Hypoxia, and Metabolism

Peptidase Inhibition and Analysis

Chat about Author

Papers

Chat

Click to start Chat